Lupin moves up on getting nod to enter into digital healthcare space

03 Jun 2021 Evaluate

Lupin is currently trading at Rs. 1248.60, up by 1.70 points or 0.14% from its previous closing of Rs. 1246.90 on the BSE.

The scrip opened at Rs. 1256.90 and has touched a high and low of Rs. 1256.90 and Rs. 1234.55 respectively. So far 40367 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1267.50 on 02-Jun-2021 and a 52 week low of Rs. 828.65 on 27-Jul-2020.

Last one week high and low of the scrip stood at Rs. 1267.50 and Rs. 1190.55 respectively. The current market cap of the company is Rs. 56789.43 crore.

The promoters holding in the company stood at 46.86%, while Institutions and Non-Institutions held 40.46% and 12.69% respectively.

Lupin has received approval from board of directors to enter into the digital healthcare space with a focus to provide a digital therapeutics platform for doctors and patients in India. The Company recently incorporated a new entity in the name of Lupin Digital Health, as a wholly owned subsidiary, which will undertake this.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2114.10 33.75 (1.62%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×